We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Analysis Compared for Accurate Pleural Fluid pH Determination

By LabMedica International staff writers
Posted on 12 Mar 2019
Print article
Image: The pHOx Ultra blood gas analyzer is used for routine blood gas analysis (Photo courtesy of Nova Biomedical).
Image: The pHOx Ultra blood gas analyzer is used for routine blood gas analysis (Photo courtesy of Nova Biomedical).
Pleural effusion is the pathological accumulation of pleural fluid resulting from excess fluid production and/or increased transpleural pressure, increased capillary permeability, and impaired lymphatic drainage.

Pleural effusion occurs in many pulmonary or systemic diseases such as infection, liver cirrhosis, congestive heart failure, and malignancy. For assessment and differential diagnosis of the cause of pleural effusion, pleural fluid pH is one of the most useful indicators, along with the widely recommended indicators such as total protein, lactate dehydrogenase, and glucose levels.

Medical Laboratory Scientists at the Yonsei University College of Medicine (Seoul, Republic of Korea) evaluated from in- and out-patient samples obtained from thoracentesis or pigtail catheter drainage and submitted to the laboratory for routine body fluid analysis. The Clot Catcher, a disposable and single-use device designed to filter off microclots or debris, was inserted between the syringe and the blood gas analyzer.

The i-STAT G3+, a cartridge-based blood gas analyzer, was used as a reference analyzer for comparison with the other three methods. The i-Smart 300, a recently introduced cartridge-based blood gas analyzer, was evaluated for comparison. The Nova Biomedical pHOx Ultra now in use for routine arterial blood gas analysis in their laboratory, and pH indicator paper was also compared.

The scientists reported that the within-device precision of all three blood gas analyzers was acceptable within 0.1% according to the desirable precision criteria. For the i-STAT G3+, within-device CV(%) at low (pH 7.04) and high levels (pH 7.76) was 0.05% and 0.04%, respectively. For the pHOx Ultra, total CV(%) was 0.03% for all levels (pH 7.13, 7.35, and 7.59). For the i-Smart 300, total CV(%) at low, mid, and high levels (pH 7.13, 7.36 and 7.59, respectively) was 0.09%, 0.08%, and 0.09%, respectively.

The i-Smart 300 showed good agreement with i-STAT G3+, with a slope of 0.85 (95% CI, 0.800–0.906). The pHOx Ultra showed about 30% lower pH values than the i-STAT G3+. The slope of equation for pH indicator paper was 1.105, with a relatively wide range of 95% CI (0.781−1.581).

The authors concluded that pleural fluid pH determination using both blood gas analyzers, the i-Smart 300 and pHOx Ultra, is sufficiently accurate for diagnosing complicated parapneumonic effusion (CPPE), if pleural fluid is collected anaerobically in a heparinized syringe and a Clot Catcher is used to protect blood gas analyzers. The study was published on January 29, 2019, in the journal Practical Laboratory Medicine.

Related Links:
Yonsei University College of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.